Abstract
BackgroundReports suggest that a large proportion of patients who acquire and use biologic DMARD agents (biologics) to treat Rheumatoid Arthritis (RA) do not acquire or adequately consume traditional DMARDs (DMARDs)(1,2)....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have